Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: Successful treatment for new and rare entity

Mouna Jerbi; Rym El Fatmi; Hanene Gaied; Dorra Belloumi; Lamia Torjemane; Raja Aoudia; Rim Goucha; Taieb Ben Abdallah; Tarek Ben Othman

doi:10.1002/ccr3.3439

Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: Successful treatment for new and rare entity

Clin Case Rep. 2020 Nov 11;9(1):80-85. doi: 10.1002/ccr3.3439. eCollection 2021 Jan.

Authors

Mouna Jerbi^{1

2}, Rym El Fatmi^{2

3}, Hanene Gaied^{1

2}, Dorra Belloumi^{2

3}, Lamia Torjemane^{2

3}, Raja Aoudia⁴, Rim Goucha^{1

2}, Taieb Ben Abdallah^{2

4}, Tarek Ben Othman³

Affiliations

¹ Department of Nephrology Mongi Slim Hospital La Marsa Tunisia.
² Faculty of Medicine Tunis University of Tunis El Manar Tunis Tunisia.
³ Department of Hematology Centre National de Greffe de Moelle Osseuse Tunis Tunisia.
⁴ Department of Nephrology Charles Nicolle Hospital Tunis Tunisia.

Abstract

Proliferative glomerulonephritis with monoclonal immunoglobulin deposits is a new disorder with undefined treatment modalities. We propose cyclophosphamide-bortezomib-dexamethasone and autologous stem cell transplantation as a therapeutic protocol.

Keywords: Hematology; Nephrology; Pharmacology.

Publication types

Case Reports